Skip to main content
. 2022 Nov 7;12:1023510. doi: 10.3389/fonc.2022.1023510

Figure 5.

Figure 5

Analysis of in the mature NK-cell pool from ALL patients and healthy controls. (A) Representative FACS plots of CD3-CD20-C14-CD56+ cells at different stages of maturation according to the expression of NKG2A and CD57 from healthy controls and ALL patients. (B) Summary of data for frequencies of CD3-CD20-C14-CD56+ cells according to the expression NKG2A and CD57. Vertical lines indicate standard deviation. The horizonal lines represents the mean value. P values reports significance according to U-Mann Whitney Test one-tail. HC, healthy controls; ALL, Acute lymphoblastic leukemia patients. (C) Summary of data for relative expression, represented as the mean fluorescence intensity (MFI), of CD3-CD20-C14-CD56+ cells at different stages of maturation according to expression of NKG2A and CD57. The vertical lines indicate standard deviation. HC, healthy controls; ALL, Acute lymphoblastic leukemia patients. The horizonal lines represents the mean value. Results were considered significant at *p < 0.05, **p < 0.01 and ***p < 0.001. NS, Not Significant.